PERSONALISED DOSING OF CLADRIBINE TO TREAT MULTIPLE SCLEROSIS

被引：1
|
作者：
Mao, Zhifeng [1 ]
Alvarez-Gonzalez, Cesar [1 ,2 ]
Allen-Philbey, Kimberley [2 ]
Mathews, Joela [2 ]
Turner, Benjamin P. [1 ,2 ]
Gnanapavan, Sharmilee [1 ,2 ]
Marta, Monica [1 ,2 ]
Baker, David [1 ]
Giovannoni, Gavin [1 ,2 ]
Schmierer, Klaus [1 ,2 ]
机构：
[1] Queen Mary Univ London, Blizard Inst, London, England
[2] Barts Hlth NHS Trust, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷
关键词：
D O I：
10.1136/jnnp-2017-ABN.164
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PO134
引用
收藏
页码：A47 / A48
页数：2
相关论文
共 50 条
  • [1] Cladribine personalised dosing to treat multiple sclerosis
    Mao, Z.
    Alvarez-Gonzalez, C.
    Allen-Philbey, K.
    Turner, B.
    Gnanapavan, S.
    Marta, M.
    Mathews, J.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 609 - 609
  • [2] Cladribine personalised dosing to treat multiple sclerosis: observations in 208 patients
    Allen-Philbey, K.
    De Trane, S.
    Stennett, A.
    Yildiz, O.
    Adams, A.
    Turner, B.
    Marta, M.
    Gnanapavan, S.
    Bianchi, L.
    Mathews, J.
    Altmann, D.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 522 - 523
  • [3] Personalised dosing of cladribine for people with multiple sclerosis
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Yildiz, Ozlem
    Allen-Philbey, Kimberley
    Turner, Benjamin
    Gnananpavan, Sharmilee
    Marta, Monica
    Mathews, Joela
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    [J]. NEUROLOGY, 2018, 90
  • [4] Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients
    Allen-Philbey, K.
    De Trane, S.
    Stennett, A.
    Yildiz, O.
    Adams, A.
    Turner, B.
    Marta, M.
    Gnanapavan, S.
    Bianchi, L.
    Mathews, J.
    Giovannoni, G.
    Baker, D.
    Schmierer, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 90 - 91
  • [5] Cladribine personalised dosing for active multiple sclerosis: BartsMS cohort follow-up
    Allen-Philbey, Kimberley
    De Trane, Stefania
    Stennett, Andrea
    Yildiz, Ozlem
    Adams, Ashok
    Turner, Ben
    Marta, Monica
    Gnanapavan, Sharmilee
    Bianchi, Lucia
    Mathews, Joela
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    [J]. NEUROLOGY, 2021, 96 (15)
  • [6] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Giovannoni, Gavin
    [J]. NEUROTHERAPEUTICS, 2017, 14 (04) : 874 - 887
  • [7] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Gavin Giovannoni
    [J]. Neurotherapeutics, 2017, 14 : 874 - 887
  • [8] Personalised dosing of monoclonal antibodies in multiple sclerosis
    Van Kempen, Z.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 10 - 10
  • [9] Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
    Allen-Philbey, Kimberley
    De Trane, Stefania
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Mathews, Joela
    MacDougall, Amy
    Stennett, Andrea
    Zhou, Xia
    Yildiz, Ozlem
    Adams, Ashok
    Bianchi, Lucia
    Blain, Camilla
    Chapman, Christine
    Chung, Karen
    Constantinescu, Cris S.
    Dalton, Catherine
    Farrell, Rachel A.
    Fisniku, Leonora
    Ford, Helen
    Gran, Bruno
    Hobart, Jeremy
    Khaleeli, Zhaleh
    Mattoscio, Miriam
    Pavitt, Sue
    Pearson, Owen
    Peruzzotti-Jametti, Luca
    Scalfari, Antonio
    Sharrack, Basil
    Silber, Eli
    Tallantyre, Emma C.
    Webb, Stewart
    Turner, Benjamin P.
    Marta, Monica
    Gnanapavan, Sharmilee
    Juliusson, Gunnar
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [10] Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis
    Alvarez-Gonzalez, Cesar
    Adams, Ashok
    Mathews, Joela
    Turner, Benjamin P.
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (07): : 506 - 511
12345